- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.02. | Apollomics Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 23.12.25 | Apollomics H1 Loss Narrows | 2 | RTTNews | ||
| 22.12.25 | Apollomics GAAP EPS of -$11.37 | 3 | Seeking Alpha | ||
| 22.12.25 | Apollomics Inc.: Apollomics Reports First Half 2025 Financial Results | 117 | GlobeNewswire (Europe) | FOSTER CITY, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) ("Apollomics" or the "Company"), a late-stage clinical biopharmaceutical company developing multiple oncology... ► Artikel lesen | |
| 22.12.25 | Apollomics Inc. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 12.12.25 | Apollomics Inc. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 19.11.25 | Apollomics Inc.: Apollomics Announces Settlement of Cayman Litigation | 127 | GlobeNewswire (Europe) | FOSTER CITY, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. ("Apollomics" or the "Company") (Nasdaq: APLM) announced today entering into a settlement agreement (the "Settlement Agreement"... ► Artikel lesen | |
| APOLLOMICS Aktie jetzt für 0€ handeln | |||||
| 18.11.25 | Apollomics Inc. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 18.11.25 | Apollomics appoints Dr. Ya-Chi Huang to board following resignation | 2 | Investing.com | ||
| 18.11.25 | Apollomics Inc.: Apollomics Announces Changes to its Board of Directors and Composition of Committees | 1 | GlobeNewswire (USA) | ||
| 15.10.25 | Apollomics Inc.: Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation | 185 | GlobeNewswire (Europe) | FOSTER CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) ("Apollomics" or the "Company"), a California based late-stage clinical biopharmaceutical company developing multiple... ► Artikel lesen | |
| 14.10.25 | Nasdaq, Inc.: Nasdaq Resumes Trading in Apollomics Inc. | 3 | GlobeNewswire (USA) | ||
| 14.10.25 | Apollomics Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 14.10.25 | Apollomics Inc.: Apollomics, Inc. Company Operational Continuity Update | 164 | GlobeNewswire (Europe) | FOSTER CITY, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) ("Apollomics" or the "Company"), today announced the following company operational update. Apollomics is a clinical-stage... ► Artikel lesen | |
| 25.09.25 | Apollomics Inc. - 6-K, Report of foreign issuer | 13 | SEC Filings | ||
| 17.09.25 | Nasdaq, Inc.: Nasdaq Halts Apollomics Inc., Ltd. | 13 | GlobeNewswire (USA) | ||
| 03.04.25 | Apollomics Inc.: Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress | 378 | GlobeNewswire (Europe) | Strategic collaboration with LaunXP for the development of vebreltinib in combination with an EGFR inhibitor ("EGFRi") to bring in $10 million upfront payment and expand dataset to combination therapyNew... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIONTECH | 87,05 | -0,51 % | BioNTech-Konkurrent Moderna: Satter Kurssprung - jetzt noch einsteigen? | Die Aktie von Moderna hat zuletzt erneut kräftigen Rückenwind erhalten. Die Korrektur seit Ende Januar wurde damit nicht nur vollständig wieder ausgeglichen, das Papier konnte sogar auf ein neues Jahreshoch... ► Artikel lesen | |
| EVOTEC | 5,402 | -1,13 % | Shortseller-Positionen aktuell: Evotec, Gerresheimer, HelloFresh, Renk, Hypoport, Symrise, TUI | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| AMGEN | 316,00 | -0,74 % | Leerink Partners senkt Amgen-Prognose für Q1 wegen Lagerbestandsabbau | ||
| NANOREPRO | 1,510 | -1,95 % | NanoRepro: "Kaltes Plasma stärkt die Haut" | NanoRepro setzt mit dem Marktstart ihres Kaltplasmageräts PHLAS ein strategisches Signal: Weg von einmaligen Sondereffekten, hin zu planbaren, margenstarken Erlösmodellen im Health- und Lifestyle-Segment.... ► Artikel lesen | |
| BIOXXMED | 1,170 | -1,68 % | XFRA NEW INSTRUMENTS AVAILABLE ON 14.01.2026 | The following instruments on XETRA do have their first trading 14.01.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 14.01.2026
Aktien
1 MHY3130D1013 Heidmar Maritime Hldgs.... ► Artikel lesen | |
| VIKING THERAPEUTICS | 28,380 | -0,18 % | Viking Therapeutics, Inc.: Viking Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update | Conference call scheduled for 4:30 p.m. ET today
Oral VK2735 to Advance into Phase 3 for Obesity in 3Q26
Phase 3 VANQUISH Trials for Subcutaneous VK2735 in Obesity... ► Artikel lesen | |
| SIRONA BIOCHEM | 0,037 | -100,00 % | Sirona Biochem Corp: Sirona Biochem downgraded to NEX | ||
| DEFENCE THERAPEUTICS | 0,381 | -2,81 % | Defence Therapeutics Inc.: Defence Therapeutics to Showcase Accum Platform at Key International Industry Events in March | Montreal, Quebec--(Newsfile Corp. - March 2, 2026) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology company advancing... ► Artikel lesen | |
| NUREXONE BIOLOGIC | 0,393 | +1,55 % | Vom Labor in die Klinik: NurExone sichert die Reproduzierbarkeit seiner Exosomen-Produktion | ||
| ABIVAX | 93,70 | -0,11 % | EQS-News: ABIVAX: Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026 | EQS-News: ABIVAX
/ Key word(s): Study results
Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory... ► Artikel lesen | |
| IBIO | 2,220 | -1,77 % | Jones Trading initiates iBio stock with buy rating on obesity platform | ||
| REDHILL BIOPHARMA | 0,920 | +0,89 % | RedHill Biopharma Ltd. - 6-K, Report of foreign issuer | ||
| ARROWHEAD PHARMACEUTICALS | 51,30 | -0,54 % | S&P Dow Jones Indices: Ciena Set to Join S&P 500; Arrowhead Pharmaceuticals to Join S&P MidCap 400; ADT and OneSpaWorld Holdings to Join S&P SmallCap 600 | NEW YORK, Feb. 4, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, S&P SmallCap 600:
S&P MidCap 400... ► Artikel lesen | |
| CELLECTIS | 3,190 | +0,16 % | Cellectis Inc.: Monthly information on share capital and company voting rights | ||
| VOYAGER THERAPEUTICS | 3,326 | -0,89 % | Voyager Therapeutics, Inc.: Voyager Reports Third Quarter 2025 Financial and Operating Results | - Momentum building around tau: expect VY7523 clinical data and VY1706 clinical entry in 2026 - - Sharpened focus on multi-modality pipeline with introduction of Voyager NeuroShuttle discovery... ► Artikel lesen |
Das Unternehmen APOLLOMICS INC kann der Branche Biotechnologie zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,500 (+2,50 %) liegt der Kurs bei 20,500 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu APOLLOMICS INC finden Sie auf Wallstreet Online.